Patients with chronic inflammatory conditions such as rheumatoid arthritis, lupus, and psoriasis may face a significantly reduced risk of blood clots when treated with glucagon-like peptide-1 (GLP-1) receptor agonists. According …
Tag:
Agonist
-
-
Type 2 Diabetes: Combining GLP-1 Therapy with Lifestyle Changes Reduces Heart Risk Individuals with type 2 diabetes (T2D) can significantly lower their risk of cardiovascular disease by combining the apply …
-
Technology
Dapiglutide Trial: Dual Gut Hormone Agonist Shows Promise But Fails to Beat Placebo for Obesity
Dapiglutide: Novel GLP-1/GLP-2 Agonist Shows Promise in Early Obesity Trials A new drug, dapiglutide, combining GLP-1 and GLP-2 receptor activation, is being investigated as a potential treatment for obesity. Early …
-
DMT Shows Promise in Rapidly Reducing Depressive Symptoms A recent clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation and the need for …
-
Opioid receptors are fantastic targets for treating pain-but regrettably, the drugs that target them can be addictive. Because the molecules suppress breathing and heart function, those drugs can also be …
-
GLP-1 Signaling in the Brain Drives Body-Wide Rejuvenation, Offering Weight-Neutral Path to healthy Aging Table of Contents GLP-1 Signaling in the Brain Drives Body-Wide Rejuvenation, Offering Weight-Neutral Path to healthy …
-
“`html Weight-Loss Surgery and Longevity in Obesity and Type 2 Diabetes Weight-Loss Surgery Linked to Increased Longevity for Those with Obesity and Type 2 Diabetes Table of Contents Weight-Loss Surgery …